uric acid has been researched along with Infections, Salmonella in 2 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, B | 1 |
| Nakamura, T | 1 |
| Inouye, K | 1 |
| Li, J | 1 |
| Tang, Y | 1 |
| Lundbäck, P | 1 |
| Valdes-Ferrer, SI | 1 |
| Olofsson, PS | 1 |
| Kalb, T | 1 |
| Roth, J | 1 |
| Zou, Y | 1 |
| Erlandsson-Harris, H | 1 |
| Yang, H | 1 |
| Ting, JP | 1 |
| Wang, H | 1 |
| Andersson, U | 1 |
| Antoine, DJ | 1 |
| Chavan, SS | 1 |
| Hotamisligil, GS | 1 |
| Tracey, KJ | 1 |
| Ogura, Y | 1 |
| Sutterwala, FS | 1 |
| Flavell, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC): A Phase II Clinical Study[NCT01984892] | Phase 2 | 8 participants (Actual) | Interventional | 2013-11-30 | Terminated (stopped due to PI discretion, low enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Patients who are alive on the date of closing follow-up, or 30 months after completing all study treatments, will be censored on that date (NCT01984892)
Timeframe: up to 30 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Participants With Stage 4 Cancer | 8 |
"Progression-free survival defined as the time in weeks from study entry until tumor progression defined using the Wolchok criteria or death. Patients who are alive and free from progression on the date of closing follow-up will be censored on that date.~In order to minimize the potential for misdiagnosis of pseudoprogression, related to early inflammation, tumor measurement for determination of progression will be made at the earliest at 26 weeks." (NCT01984892)
Timeframe: average 52 weeks
| Intervention | weeks (Number) |
|---|---|
| Participants With Stage 4 Cancer | 41 |
1 review available for uric acid and Infections, Salmonella
| Article | Year |
|---|---|
The inflammasome: first line of the immune response to cell stress.
Topics: Adenosine Triphosphate; Animals; Apoptosis Regulatory Proteins; Calcium Pyrophosphate; Calcium-Bindi | 2006 |
1 other study available for uric acid and Infections, Salmonella
| Article | Year |
|---|---|
Novel role of PKR in inflammasome activation and HMGB1 release.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Animals; Antigens, Bacterial; Apoptosi | 2012 |